# Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder

> **NCT07192367** · PHASE4 · RECRUITING · sponsor: **Emine Kanmaz** · enrollment: 56 (estimated)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **BEHAVIORAL:** Virtual Reality Exposure Therapy
- **DRUG:** Sertraline (Oral Antidepressant)

## Key facts

- **NCT ID:** NCT07192367
- **Lead sponsor:** Emine Kanmaz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2026-08
- **Final completion:** 2026-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07192367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07192367, "Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07192367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*